These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18359028)

  • 21. Risk of cardiovascular events predicted by the Rama-EGAT score among HIV-infected patients in Thailand.
    Suppadungsuk S; Yamwong S; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2013 Sep; 44(5):818-24. PubMed ID: 24437317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.
    Moreno-Torres A; Domingo P; Pujol J; Blanco-Vaca F; Arroyo JA; Sambeat MA
    Antivir Ther; 2007; 12(2):195-203. PubMed ID: 17503662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial dysfunction, increased inflammation, and activated coagulation in HIV-infected patients improve after initiation of highly active antiretroviral therapy.
    Arildsen H; Sørensen KE; Ingerslev JM; Østergaard LJ; Laursen AL
    HIV Med; 2013 Jan; 14(1):1-9. PubMed ID: 22639788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic complications and selected cytokines in HIV-infected individuals.
    Bociąga-Jasik M; Polus A; Góralska J; Śliwa A; Raźny U; Zdzienicka A; Garlicki A; Mach T; Dembińska-Kieć A
    Pol Arch Med Wewn; 2014; 124(1-2):27-35. PubMed ID: 24343092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of inflammatory cytokines and endothelial adhesion molecules with immunological, virological, and cardiometabolic disease in HIV-infected individuals.
    Lacerda HR; Falcão Mda C; de Albuquerque VM; Zírpoli JC; Miranda-Filho Dde B; de Albuquerque Mde F; Montarroyos U; Ximenes RA
    J Interferon Cytokine Res; 2014 May; 34(5):385-93. PubMed ID: 24359573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular risk assessment using high-sensitivity C-reactive protein in patients with erectile dysfunction.
    Ferrandis-Cortes C; Martínez-Jabaloyas JM; Díez-Calzadilla NA; Hernández-Medina JA; Chuan-Nuez P
    Urol Int; 2013; 91(2):187-91. PubMed ID: 23816857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
    Keiser PH; Sension MG; DeJesus E; Rodriguez A; Olliffe JF; Williams VC; Wakeford JH; Snidow JW; Shachoy-Clark AD; Fleming JW; Pakes GE; Hernandez JE;
    BMC Infect Dis; 2005 Jan; 5():2. PubMed ID: 15647105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impacts of current antiretroviral therapy regimens on Chinese AIDS patients and their implications for HIV-1 drug resistance mutation.
    Zhang M; Han XX; Cui WG; Jia MH; Meng XD; Xing AH; Wu YH; Yang YY; Lu CM; Hu QH; Dai D; Zhang ZN; Shang H
    Jpn J Infect Dis; 2008 Sep; 61(5):361-5. PubMed ID: 18806342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS.
    Levy AR; McCandless L; Harrigan PR; Hogg RS; Bondy G; Iloeje UH; Mukherjee J; Montaner JS
    Lipids Health Dis; 2005 Feb; 4():4. PubMed ID: 15705191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence of C-reactive protein levels in adult population in two regions in the czech republic and their relation to body composition].
    Cerovská J; Hoskovcová P; Vosátková M; Zamrazilová H; Zamrazil V
    Vnitr Lek; 2006 Nov; 52(11):1045-50. PubMed ID: 17165523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women.
    Lee K; Lee S; Kim YJ; Kim YJ
    Nutrition; 2008; 24(7-8):625-31. PubMed ID: 18485667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients.
    Domingo P; Lamarca MK; Gallego-Escuredo JM; Torres F; Domingo JC; Villarroya J; Gutierrez Mdel M; Mateo MG; Vidal F; Villarroya F; Giralt M
    J Antimicrob Chemother; 2015; 70(6):1825-32. PubMed ID: 25700720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body shape and metabolic abnormalities in Thai HIV-infected patients.
    Homsanit M; Nelson KE; Sonjai A; Anekthananon T; Suwanagool S; Cofrancesco J
    AIDS Res Hum Retroviruses; 2007 Nov; 23(11):1314-21. PubMed ID: 18184072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study.
    De Luca A; de Gaetano Donati K; Colafigli M; Cozzi-Lepri A; De Curtis A; Gori A; Sighinolfi L; Giacometti A; Capobianchi MR; D'Avino A; Iacoviello L; Cauda R; D'Arminio Monforte A
    BMC Infect Dis; 2013 Sep; 13():414. PubMed ID: 24004495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus.
    Pfützner A; Standl E; Strotmann HJ; Schulze J; Hohberg C; Lübben G; Pahler S; Schöndorf T; Forst T
    Clin Chem Lab Med; 2006; 44(5):556-60. PubMed ID: 16681424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does first line antiretroviral therapy increase the prevalence of cardiovascular risk factors in Indian patients?: A cross sectional study.
    Carey RA; Rupali P; Abraham OC; Kattula D
    J Postgrad Med; 2013; 59(4):258-62. PubMed ID: 24346381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein: a poor marker of cardiovascular disease risk in HIV+ populations with a high prevalence of elevated serum transaminases.
    Baum MK; Rafie C; Sales S; Lai S; Duan R; Jayaweera DT; Page JB; Campa A
    Int J STD AIDS; 2008 Jun; 19(6):410-3. PubMed ID: 18595880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular risks in Asian HIV-infected patients receiving boosted-protease inhibitor-based antiretroviral treatment.
    Ounjaijean S; Kulprachakarn K; Aurpibul L; Kaewpoowat Q; Boonyapranai K; Chaiwarith R; Arwon S; Supparatpinyo K; Rerkasem K
    J Infect Dev Ctries; 2021 Mar; 15(2):289-296. PubMed ID: 33690213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021.
    Mulligan K; Harris DR; Monte D; Stoszek S; Emmanuel P; Hardin DS; Kapogiannis BG; Worrell C; Meyer WA; Sleasman J; Wilson CM; Aldrovandi GM;
    Clin Infect Dis; 2010 Jan; 50(1):106-14. PubMed ID: 19947855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cardiovascular risk marker asymmetric dimethylarginine is elevated in asymptomatic, untreated HIV-1 infection and correlates with markers of immune activation and disease progression.
    Hudson CL; Zemlin AE; Ipp H
    Ann Clin Biochem; 2014 Sep; 51(Pt 5):568-75. PubMed ID: 24142400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.